Drugs / XRX-001
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00995865 Comparator | Jan → May 2010 | yellow fever | GE Healthcare | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XRX-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00995865 ↗ |
| Modality | Vaccine | “XRX-001 purified whole-virus, β-propiolactone-inactivated yellow fever vaccine” PMID 21470010 ↗ Apr 2011 |
| Route | Intramuscular | “subjects received intramuscular injections of vaccine that contained 0.48 μg or 4.8 μg of antigen” PMID 21470010 ↗ Apr 2011 |